Skip to main content
. 2024 Feb 17;11(17):2308298. doi: 10.1002/advs.202308298

Figure 4.

Figure 4

a) Schematic illustration of RAP@Fe3O4‐PDA‐CD‐PEG‐PEI‐Profilin‐1‐Cy5.5 nanoparticles. b) Representative in vivo MR images of ApoE−/− mice with PFN1‐CD‐MNPs. c,d) NIRF of the aorta and general ORO staining of the carotid artery after 2 months of various treatments. Reproduced under terms of the CC‐BY license.[ 38 ] Copyright 2019, The Authors, Published by Informa UK Limited, trading as Taylor & Francis Group. e) Schematic illustration of the synthesis of theranostic liposomes Rap/ Fe3O4@VHP‐Lipo by self‐assembly. f) The fluorescence distribution in vivo for mice with three different treatments. g) The fluorescence enrichment of the aorta from three different mice groups. h) The treatment effectiveness testing of fluorescence imaging for mice from three different groups injected with Rap/ Fe3O4@VHP‐Lipo for 2 months. i) MRI T2 mapping sequence imaging to detect the treatment effect of mice in three different groups with different treatments for 2 months. Reproduced under terms of the CC‐BY license.[ 68 ] Copyright 2022, The Authors, Published by MDPI, Basel, Switzerland.